Compare NATR & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NATR | SAR |
|---|---|---|
| Founded | 1972 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 424.6M | 372.7M |
| IPO Year | 1995 | N/A |
| Metric | NATR | SAR |
|---|---|---|
| Price | $24.84 | $21.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $28.33 | $23.75 |
| AVG Volume (30 Days) | ★ 124.6K | 110.4K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 14.40% |
| EPS Growth | ★ 165.00 | N/A |
| EPS | ★ 1.06 | N/A |
| Revenue | ★ $480,144,000.00 | N/A |
| Revenue This Year | $7.76 | N/A |
| Revenue Next Year | $3.82 | $0.39 |
| P/E Ratio | $23.21 | ★ $9.44 |
| Revenue Growth | ★ 5.67 | N/A |
| 52 Week Low | $11.24 | $20.78 |
| 52 Week High | $28.14 | $25.64 |
| Indicator | NATR | SAR |
|---|---|---|
| Relative Strength Index (RSI) | 52.21 | 46.32 |
| Support Level | $23.14 | $21.09 |
| Resistance Level | $28.00 | $23.47 |
| Average True Range (ATR) | 0.89 | 0.62 |
| MACD | 0.14 | 0.05 |
| Stochastic Oscillator | 83.14 | 53.55 |
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.